Daiwa Securities Group Inc. Immunity Bio, Inc. Transaction History
Daiwa Securities Group Inc.
- $21.6 Billion
- Q3 2024
A detailed history of Daiwa Securities Group Inc. transactions in Immunity Bio, Inc. stock. As of the latest transaction made, Daiwa Securities Group Inc. holds 2,620 shares of IBRX stock, worth $12,759. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,620
Previous 2,620
-0.0%
Holding current value
$12,759
Previous $17,000
41.18%
% of portfolio
0.0%
Previous 0.0%
Shares
10 transactions
Others Institutions Holding IBRX
# of Institutions
200Shares Held
71.4MCall Options Held
1.01MPut Options Held
1.25M-
Vanguard Group Inc Valley Forge, PA16.9MShares$82.3 Million0.0% of portfolio
-
Black Rock Inc. New York, NY11.4MShares$55.6 Million0.0% of portfolio
-
State Street Corp Boston, MA8.65MShares$42.1 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA3.85MShares$18.7 Million0.0% of portfolio
-
Morgan Stanley New York, NY2.25MShares$10.9 Million0.0% of portfolio
About ImmunityBio, Inc.
- Ticker IBRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 400,304,000
- Market Cap $1.95B
- Description
- ImmunityBio, Inc., a clinical-stage biotechnology company, develops therapies and vaccines to treat cancers and infectious diseases. It offers immunotherapy and cell therapy platforms, including antibody cytokine fusion proteins, synthetic immunomodulators, vaccine technologies, natural killer cells, and adaptive (T cell) immune systems. The com...